RENAL CARE & DATA LINKAGE OF TASMANIAN KIDNEY DISEASE CASES
With
Professor Matthew Jose, Kidney Specialist
Head of Unit, Nephrology, Royal Hobart Hospital &
Professor of Medicine, University of Tasmania
Tasmania, Australia
RESEARCHER PROFILE
Filmed in Hobart, Tasmania, Australia | March 2026
Professor Matthew Jose is a Renal Physician & Head of the Renal Unit at the Royal Hobart Hospital, and Professor of Medicine for the University of Tasmania.
Winner of the 2021 Rural Science Award from the Australia and New Zealand Society of Nephrology, he has worked in regional, rural and remote Australian locations for nearly 20 years as a Renal Physician, including the Northern Territory.
He is currently Chairperson of the Tasmanian Statewide Kidney Clinical Network and a member of national clinical guideline groups including Therapeutic Guidelines and CARI guidelines kidney stone working group, as well as a member of the KidGEN (Kidney Genetics) national steering committee.
He has established the first regional young adult transplant clinic for young Tasmanians with a kidney transplant transferring from paediatric to adult care.
Professor Jose’s research has been funded by Australia’s NHMRC and MRFF, as well as Royal Hobart Hospital Research Foundation in Tasmania.
Source: Supplied and adapted
https://orcid.org/0000-0002-9589-0071
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
Brain ageing, dementia and psychiatric disorders
Professor Perminder Sachdev graduated from the All-India Institute of Medical Sciences, New Delhi, in 1978 and completed his MD in Psychiatry there in 1983. Following time in New Zealand, he relocated to Australia, where he completed psychiatric training and a PhD at UNSW in 1991. His doctoral work examined ethnopsychological concepts in Māori culture. His early research focused on drug-induced movement disorders, including akathisia, tardive dyskinesia and neuroleptic malignant syndrome, while his later work has centred on dementia and pre-dementia syndromes, particularly neuroimaging, biomarkers and risk factors.
-
CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease
Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.
